(Q45282212)

English

The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

object named as

Serban Radian

3

0 references

Niki Karavitaki

object named as

Niki Karavitaki

1

0 references

6

object named as

John A H Wass

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

author name string

Ileana Botusan

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Mihail Coculescu

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Helen E Turner

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

62

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

282-288

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Systemic complications of acromegaly: epidemiology, pathogenesis, and management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02191.X

21 January 2018

Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02191.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02191.X

21 January 2018

Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02191.X

21 January 2018

Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02191.X

21 January 2018

Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02191.X

21 January 2018

Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02191.X

21 January 2018

Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02191.X

21 January 2018

Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02191.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2004.02191.X

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45282212&oldid=2083682582"